COMMENT: This systematic review and meta-analysis show that, for patients with low to intermediate risk papillary thyroid carcinoma, lobectomy provides recurrence-free and disease-specific survival outcomes comparable to total thyroidectomy. By demonstrating no survival advantage to more extensive surgery, the article supports guideline-aligned, risk-stratified decision-making that favors lobectomy when appropriate. These findings help clinicians counsel patients on the safety and efficacy of less aggressive surgery while reducing morbidity associated with total thyroidectomy.—Sarah Rapoport, MD
Leave a Reply